MASTL-IN-1 |
MASTL-IN-1 : Inhibitor of MASTL
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MASTL |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
MASTL-IN-15 was profiled against a panel of 394 kinases for percent inhibition at 100 nM (>3,000x ov ...
Potency Cellular
In Vitro
MASTL
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.4c01659
In Vivo Validations
Mouse
Dose: 0.5 mg/Kg IV, 30 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
1.2 h
Systemic clearance:
109 mL/min/Kg
Cmax:
725 ng/mL PO
Tmax:
2.0 h PO
Area Under the Curve::
76.2 IV, 4400 PO ng*h/mL
Bioavailability:
96% PO
Volume of Distribution at Steady-State:
4.9 L/Kg
DOI Reference: 10.1021/acs.jmedchem.4c01659
Chemical Information
| Molecular Formula | C21H25N9 |
| SMILEs | CCC(N)(CC)c1ccnc(Nc2cc3cc(-c4cnnn4C)nc(N)c3cn2)c1 |
| InChI | InChI=1S/C21H25N9/c1-4-21(23,5-2)14-6-7-24-19(10-14)28-18-9-13-8-16(17-12-26-29-30(17)3)27-20(22)15(13)11-25-18/h6-12H,4-5,23H2,1-3H3,(H2,22,27)(H,24,25,28) |
| Molecular weight | 403.22 Da |
| AlogP | 3.1201000000000008 |
| HBond acceptors | 9 |
| HBond donors | 5 |
| Atoms | 55 |